drugset / Trial / NCT01540721

Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend

NCT01540721

Phase 1 Completed 28 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-label

Summary

This study will evaluate the pharmacokinetic profiles of experimental formulations of paracetamol.

Timeline

Start
2009-12
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule

Indications

No indication recorded.